Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop
growing or die. This phase I trial is studying the side effects and best dose of decitabine
in treating children with relapsed or refractory acute myeloid leukemia or acute
lymphoblastic leukemia